LexDanaLexDanabeta
Inventor

FABRIZIO MICHELI

Inventor
IT

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,595,269Morpholine-like monoamine releasers202611,773,096Small-molecule PI5P4K alpha/beta inhibitors and methods of treatment using same202311,660,293Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to CHRONOS THERAPEUTICS LTD (1)· patent assignee history
2023Patents assigned to UNIV YALE (1)· patent assignee history
2023–2026Based in IT· patent location history
2026Patents assigned to SOLVONIS THERAPEUTICS IRELAND HOLDINGS LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHRONOS THERAPEUTICS LTD12023
SOLVONIS THERAPEUTICS IRELAND HOLDINGS LTD12026
UNIV YALE12023
Locations
LocationPatentsSpan
IT32023–2026